Scientists track how new antibiotic zidebactam exits the body
NCT ID NCT07247942
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed Phase 1 study looked at how healthy men process and eliminate the antibiotic zidebactam. Eight participants received a single dose with a radioactive tracer to track the drug in urine and feces. The goal was to understand how the drug is broken down and how quickly it leaves the body, which helps guide future dosing studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
zidebactam (an antibiotic)
What this could lead to
If successful, this study will clarify how zidebactam is broken down and removed from the body, helping to design better dosing for future patients.
What could go wrong
This is a very early, small study in just 8 healthy men. It does not test whether the drug works against infections, and results may not apply to women or sick people.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS (HS) are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Covance Clinical Research Unit Inc. 3402 Kinsman Boulevard Madison, Wisconsin 53704 USA
Madison, Wisconsin, 53704, United States